Viewing Study NCT03221166


Ignite Creation Date: 2025-12-24 @ 4:11 PM
Ignite Modification Date: 2026-03-05 @ 12:06 AM
Study NCT ID: NCT03221166
Status: TERMINATED
Last Update Posted: 2020-09-04
First Post: 2017-07-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors
Sponsor: IRCCS Burlo Garofolo
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-02-27
Start Date Type: ACTUAL
Primary Completion Date: 2020-07-31
Primary Completion Date Type: ACTUAL
Completion Date: 2020-07-31
Completion Date Type: ACTUAL
First Submit Date: 2017-07-05
First Submit QC Date: None
Study First Post Date: 2017-07-18
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-09-02
Last Update Post Date: 2020-09-04
Last Update Post Date Type: ACTUAL